The assay being referred to in this prompt is PubChem BioAssay, which is designed to confirm the dose response of uHTS inhibitor hits of the mitochondrial permeability transition pore, using a fluorescent-based counterscreen assay. This is a confirmatory type of assay that falls under the category of functional assays. Its primary goal is to validate the efficacy of potential inhibitors by ensuring that they exhibit a dose response that matches what is expected based on previous research. Does the molecule show efficacy in this assay?